Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results

Last Modified: 3/25/2008 First Published: 5/1/1998


1.		Phase III Randomized Study of Methylphenidate for Alleviation of Fatigue and Lethargy in Cancer Patients Receiving Interferon alfa

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				18 and over				NCI				E-2Z96 NCI-P98-0130, NCT00003266

Last Modified: 2/4/2008 First Published: 3/1/2002


2.		Phase III Randomized Study of d-Methylphenidate to Improve Quality of Life in Patients Receiving Radiotherapy for Primary or Metastatic Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				18 and over				NCI				CCCWFU-97600 NCI-P02-0211, NCT00031798

Last Modified: 8/1/1990


3.		Phase III Placebo-Controlled Trial of Methylphenidate plus Narcotic to Manage Pain in Patients with Cancer (Summary Last Modified 08/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				8 and over				NCI				NCCTG-899251 MAYO-899251, NCI-P90-0007

Last Modified: 8/14/2008 First Published: 9/10/2006


4.		Phase III Randomized Study of Long-Acting Methylphenidate in Patients With Cancer-Related Fatigue

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				18 and over				NCI				NCCTG-N05C7 NCCTG N05C7, N05C7, NCT00376675

Last Modified: 10/6/2008 First Published: 9/24/2003


5.		Phase II Randomized Study of Dextroamphetamine-Amphetamine Versus Methylphenidate in Pediatric Cancer Patients With Treatment-Related Neurocognitive Sequelae and Depression

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Completed				6 to 17				NCI				MCC-0201 NCI-5899, HLMCC 0201, NCT00069927


6.		Psychostimulants for Fatigue in Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Completed				18 and over				Other				02-100 NCT00138138

Select All on One Page